Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Knapp

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Life Sciences|January 1, 1990
[3H][D-Pen2, D-Pen5]enkephalin binding to delta opioid receptors on intact neuroblastoma-glioma (NG 108-15) hybrid cellsR J Knapp, H I Yamamura
Journal of Medical Education|October 1, 1979
Doctor-patient relationships in fetal/infant death encountersR J Knapp, L G Peppers
Journal of Neuroimmunology|June 1, 1986
Isolation and characterization of a new peptide from hypothalamus and pituitary using a monoclonal antibody to LHRHR J Knapp, L A Sternberger
Psychiatry|May 1, 1980
Maternal reactions to involuntary fetal/infant deathL G Peppers, R J Knapp
Journal of Neuroimmunology|August 1, 1984
High affinity monoclonal antibodies to luteinizing hormone-releasing hormone. Preparation and binding studiesR J Knapp, L A Sternberger
Cell and Tissue Research|January 1, 1984
Immunocytochemistry of a "private" luteinizing-hormone-releasing hormone system in the pituitaryJ Y Li, R J Knapp, L A Sternberger
Life Sciences|January 1, 1989
Amoxapine inhibition of GABA-stimulated chloride conductance: investigations of potential sites of activityM Ikeda, R J Knapp, E Malatynska, et al.
Life Sciences|January 1, 1988
Antidepressants and seizure-interactions at the GABA-receptor chloride-ionophore complexE Malatynska, R J Knapp, M Ikeda, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|February 1, 1989
Structural characteristics of two highly selective opioid peptidesR J Knapp, W Kazmierski, V J Hruby, et al.
Neuroreport|June 19, 1995
The role of the Val353 residue in antagonist binding to rat CCK-B receptorsE Malatynska, R J Knapp, D Stropova, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Life Sciences|January 1, 1990
[3H][D-Pen2, D-Pen5]enkephalin binding to delta opioid receptors on intact neuroblastoma-glioma (NG 108-15) hybrid cellsR J Knapp, H I Yamamura
Journal of Medical Education|October 1, 1979
Doctor-patient relationships in fetal/infant death encountersR J Knapp, L G Peppers
Journal of Neuroimmunology|June 1, 1986
Isolation and characterization of a new peptide from hypothalamus and pituitary using a monoclonal antibody to LHRHR J Knapp, L A Sternberger
Psychiatry|May 1, 1980
Maternal reactions to involuntary fetal/infant deathL G Peppers, R J Knapp
Journal of Neuroimmunology|August 1, 1984
High affinity monoclonal antibodies to luteinizing hormone-releasing hormone. Preparation and binding studiesR J Knapp, L A Sternberger
Cell and Tissue Research|January 1, 1984
Immunocytochemistry of a "private" luteinizing-hormone-releasing hormone system in the pituitaryJ Y Li, R J Knapp, L A Sternberger
Life Sciences|January 1, 1989
Amoxapine inhibition of GABA-stimulated chloride conductance: investigations of potential sites of activityM Ikeda, R J Knapp, E Malatynska, et al.
Life Sciences|January 1, 1988
Antidepressants and seizure-interactions at the GABA-receptor chloride-ionophore complexE Malatynska, R J Knapp, M Ikeda, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|February 1, 1989
Structural characteristics of two highly selective opioid peptidesR J Knapp, W Kazmierski, V J Hruby, et al.
Neuroreport|June 19, 1995
The role of the Val353 residue in antagonist binding to rat CCK-B receptorsE Malatynska, R J Knapp, D Stropova, et al.
Pageof 5